• (PLX AI) – Novo Nordisk says Wegovy recommended for approval for the treatment of obesity by the European regulatory authorities.
  • • Novo Nordisk expects to receive final marketing authorisation from the European Commission in approximately two months
  • • The positive CHMP opinion is based on results from the STEP phase 3a clinical trial program
  • • Wegovy was launched in the US in June 2021

Quelle: PLX AI